16/06/2026
Researchers have developed a CRISPR-based technique that targets cancer cells carrying specific genetic mutations. The method works by disrupting chromatin, a structure that helps organize DNA inside cells, causing affected cancer cells to break down.
Early studies suggest the approach could be useful against cancers that do not respond well to existing treatments. This has generated excitement because many of these cancers have been difficult to target with traditional medicines.
While the research is still in its early stages, scientists believe this technology could lead to more precise cancer therapies with fewer side effects. More studies are needed before it can be widely used in patients.
Source/Credit: Recent research on CRISPR-based chromatin-targeting cancer therapies